Lexapro vs. Effexor

See how Lexapro and Effexor compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Lexapro is an SSRI approved for depression and anxiety in adults, while Effexor is an SNRI also approved for social anxiety and panic disorder, giving it broader FDA coverage.

  • Effexor causes nausea, dizziness, and dry mouth at notably higher rates than Lexapro, and needs careful titration plus blood pressure monitoring at higher doses.

  • Both drugs carry a boxed warning for increased suicidal thoughts in younger patients and cannot be combined with MAOIs.

Lexapro vs. Effexor Drug Summary

Lexapro

Lexapro (escitalopram) is a selective serotonin reuptake inhibitor (SSRI) approved for major depressive disorder in adults and adolescents ages 12 to 17, and for generalized anxiety disorder in adults. It's taken as a once-daily tablet or oral solution, usually starting at 10 mg and increasing to 20 mg after two weeks if needed.

Effexor

Effexor (venlafaxine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved for major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder. It's taken as a once-daily extended-release capsule, starting at 37.5 mg and titrated up to a maximum of 225 mg based on response.

Lexapro vs. Effexor Side Effects

Lexapro

Most common
Nausea (up to 15%)
Somnolence (up to 6%)
Insomnia (up to 9%)
Ejaculation disorder (up to 9%)

Effexor

Most common
Nausea (up to 37%)
Somnolence (up to 23%)
Dry mouth (up to 22%)
Dizziness (up to 19%)

Lexapro vs. Effexor Dosage

Lexapro

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 20 mg once daily Week 2 onward
Maximum dose 20 mg once daily Same as starting
Dose changes None Fixed dose

Effexor

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 37.5 mg once daily Days 1-7
Maximum dose 75 mg once daily Day 8 onward
Dose changes 1 increase Every 7 days

Lexapro vs. Effexor Indications

Lexapro

Lexapro is FDA-approved for major depressive disorder in adults and in adolescents ages 12 to 17, as well as generalized anxiety disorder in adults. It is not approved for MDD in children under 12 or for GAD in any pediatric patients.

  • Major depressive disorder (adults and adolescents 12-17)

  • Generalized anxiety disorder (adults only)

  • Not approved for MDD in children under 12

  • Not approved for GAD in pediatric patients

Effexor

Effexor is FDA-approved for major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder with or without agoraphobia in adults. It is also used off-label for chronic nerve pain and menopausal hot flashes, though it is not approved for pediatric use or bipolar depression.

  • Major depressive disorder (adults)

  • Generalized anxiety disorder (adults)

  • Social anxiety disorder (adults)

  • Panic disorder, with or without agoraphobia

Lexapro vs. Effexor Pros and Cons

Lexapro

Lexapro is generally well tolerated, with a straightforward two-step dosing schedule and a narrower, more targeted set of approved uses. As a single-mechanism SSRI, it tends to cause less dizziness and blood pressure change than dual-action antidepressants like Effexor.

Pros

  • Simple two-step dosing (10 mg then 20 mg) with no complex titration

  • No blood pressure monitoring needed, unlike venlafaxine

  • FDA-approved specifically for adolescents with major depressive disorder

  • Lower rates of nausea, dizziness, and dry mouth than venlafaxine

Cons

  • Narrower FDA approval: only MDD and GAD, not panic or social anxiety disorder

  • Sexual side effects, including ejaculation disorder, are common in men

  • Not used off-label for chronic pain or hot flashes like Effexor

Effexor

Effexor's dual action on serotonin and norepinephrine gives it broader FDA approval across mood and anxiety disorders, but its side effect profile and monitoring needs are more involved. Higher doses can raise blood pressure, and the multi-step titration and taper schedule require more oversight than Lexapro's simpler dosing.

Pros

  • FDA-approved for four conditions: MDD, GAD, social anxiety disorder, and panic disorder

  • Dual serotonin-norepinephrine action can help when SSRIs alone aren't enough

  • Also used off-label for chronic nerve pain and menopausal hot flashes

  • Extended-release capsule allows once-daily dosing instead of multiple doses with immediate-release tablets

Cons

  • Multi-step titration up to 225 mg, more complex than Lexapro's two doses

  • Can raise blood pressure at higher doses, requiring monitoring

  • Higher rates of nausea, dizziness, and dry mouth reported

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.